Healthpeak Properties (NYSE:DOC) Posts Earnings Results, Beats Expectations By $0.05 EPS

Healthpeak Properties (NYSE:DOC) issued its quarterly earnings results on Tuesday. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05, FiscalAI reports. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties updated its FY 2026 guidance to 1.730-1.770 EPS.

Healthpeak Properties Stock Performance

DOC stock traded down $0.05 during midday trading on Tuesday, reaching $21.59. The company had a trading volume of 7,351,582 shares, compared to its average volume of 8,640,509. The firm has a market capitalization of $14.89 billion, a PE ratio of 67.48, a P/E/G ratio of 3.39 and a beta of 1.02. The stock has a 50 day moving average price of $21.05 and a 200 day moving average price of $18.70. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on DOC shares. Barclays initiated coverage on shares of Healthpeak Properties in a research report on Tuesday, July 7th. They issued an “equal weight” rating and a $23.00 target price for the company. Citigroup lifted their price target on Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. BMO Capital Markets boosted their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, June 15th. Wells Fargo & Company upped their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 15th. Finally, JPMorgan Chase & Co. increased their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Four investment analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $20.62.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently modified their holdings of the company. Advocate Investing Services LLC bought a new stake in Healthpeak Properties in the 4th quarter valued at about $26,000. CYBER HORNET ETFs LLC bought a new stake in shares of Healthpeak Properties during the second quarter valued at approximately $33,000. Wiser Advisor Group LLC bought a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $38,000. DV Equities LLC acquired a new position in shares of Healthpeak Properties during the fourth quarter worth approximately $36,000. Finally, Los Angeles Capital Management LLC bought a new position in Healthpeak Properties in the 4th quarter worth approximately $55,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.